Skip to content

Clinical trials

Observational Cognitive Dysfunction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Observational Country / region: United States Clear all

268 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20035
20044
20052
20063
20075
20087
20097
20109
20119
20127
201311
20149
201515
201618
201713
201814
201912
202013
202129
202220
202321
202411
202510
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed141
Recruiting43
Active, not recruiting22
Unknown status22
Enrolling by invitation14
Terminated14
Withdrawn8
Not yet recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Aging (NIA)8
Ohio State University8
Stanford University8
Vanderbilt University Medical Center8
University of Southern California7
Brigham and Women's Hospital6
Duke University6
Massachusetts General Hospital6
Tammie L. S. Benzinger, MD, PhD6
Wake Forest University Health Sciences6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction268
Alzheimer Disease118
Dementia80
Memory Disorders17
Breast Neoplasms14
Delirium12
Cognition Disorders10
Dementia, Vascular10
Neurodegenerative Diseases10
Brain Diseases9

Trials

Showing 1 to 25 of 268. Each trial links to its page on Pharma Observatory.

168 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.